Antibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- AFC-043CL - Provider product page
- Provider
- Creative Biolabs
- Product name
- Afuco? Anti-Human AOC3 ADCC Recombinant Antibody (BTT-1023), ADCC Enhanced
- Antibody type
- Monoclonal
- Description
- Anti-AOC3 ADCC Enhanced Antibody (BTT-1023) is an ADCC enhanced antibody produced by our Afuco? platform. BTT1023 is a fully human monoclonal antibody targeting VAP-1 (vascular adhesion protein-1). VAP-1 is a completely new therapeutic target. The safety and efficacy of BTT1023 has earlier been investigated in small clinical trials in rheumatoid arthritis and psoriasis patients. In March 2015, BTT1023 transitioned into Phase 2 development in fibrotic conditions and received Orphan Drug Designation in the EU for the treatment of primary sclerosing cholangitis.
- Reactivity
- Human
- Storage
- Store at 4¡ãC for up to 3 months. For longer term storage aliquot into small volumes and store at -20¡ãC.
No comments: Submit comment
No validations: Submit validation data